Cargando…

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GSD) often coexist in the general population owing to shared risk factors. This study explored the relationship between NAFLD and GSD in patients with type 2 diabetes. METHODS: We conducted a retrospective cross-sectional an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ye, Hu, Lili, Song, Jing, Wan, Jing, Chen, Haibing, Yin, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603504/
https://www.ncbi.nlm.nih.gov/pubmed/34794397
http://dx.doi.org/10.1186/s12902-021-00899-z
_version_ 1784601778041389056
author Lu, Ye
Hu, Lili
Song, Jing
Wan, Jing
Chen, Haibing
Yin, Jun
author_facet Lu, Ye
Hu, Lili
Song, Jing
Wan, Jing
Chen, Haibing
Yin, Jun
author_sort Lu, Ye
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GSD) often coexist in the general population owing to shared risk factors. This study explored the relationship between NAFLD and GSD in patients with type 2 diabetes. METHODS: We conducted a retrospective cross-sectional analysis of 4325 patients with type 2 diabetes. GSD and NAFLD were confirmed using ultrasonography. GSD was defined as either asymptomatic gallstones or previous cholecystectomy, and each was analyzed separately. RESULT: There was no significant difference in the prevalence of GSD between patients with and without NAFLD (23.8% vs. 21.2%, P = 0.15). After case–control matching (1:1) of baseline data such as age, sex, duration of diabetes, and HbA1c between patients with and without NAFLD, there was still no significant difference in the prevalence of GSD (25.5% vs. 23.6%, P = 0.15). The prevalence of NAFLD in patients with asymptomatic gallstones was lower than that of patients without GSD (38.6% vs. 47.3%, P < 0.001), whereas the prevalence in those who had undergone cholecystectomy was much higher (61.2% vs. 47.3%, P < 0.001). The ratio of cholecystectomy to asymptomatic gallstone in patients with or without NAFLD was 1.97 and 0.79, respectively. The rate of cholecystectomy was higher in the patients with NAFLD than in those without NAFLD (15.8% vs. 9.3%, P < 0.001), consistent with the result after case–control matching (17.3% vs. 11.2%, P < 0.001). Multivariate logistic regression analysis, after adjusting for numerous potential confounding factors, revealed that GSD (OR = 1.241, 95%CI: 1.036–1.488, P = 0.002) and cholecystectomy (OR = 1.946, 95%CI: 1.546–2.445, P < 0.001) were both strongly associated with NAFLD. However, asymptomatic gallstone (OR = 0.663, 95%CI: 0.513–0.856, P = 0.002) seemed to be negatively correlated with NAFLD. CONCLUSIONS: The prevalence of GSD was similar in patients with type 2 diabetes with and without NAFLD. The higher proportion of cholecystectomy and lower proportion of asymptomatic gallstones in patients with NAFLD suggests that NAFLD may increase the risk of complications of GSD.
format Online
Article
Text
id pubmed-8603504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86035042021-11-19 Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study Lu, Ye Hu, Lili Song, Jing Wan, Jing Chen, Haibing Yin, Jun BMC Endocr Disord Research BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GSD) often coexist in the general population owing to shared risk factors. This study explored the relationship between NAFLD and GSD in patients with type 2 diabetes. METHODS: We conducted a retrospective cross-sectional analysis of 4325 patients with type 2 diabetes. GSD and NAFLD were confirmed using ultrasonography. GSD was defined as either asymptomatic gallstones or previous cholecystectomy, and each was analyzed separately. RESULT: There was no significant difference in the prevalence of GSD between patients with and without NAFLD (23.8% vs. 21.2%, P = 0.15). After case–control matching (1:1) of baseline data such as age, sex, duration of diabetes, and HbA1c between patients with and without NAFLD, there was still no significant difference in the prevalence of GSD (25.5% vs. 23.6%, P = 0.15). The prevalence of NAFLD in patients with asymptomatic gallstones was lower than that of patients without GSD (38.6% vs. 47.3%, P < 0.001), whereas the prevalence in those who had undergone cholecystectomy was much higher (61.2% vs. 47.3%, P < 0.001). The ratio of cholecystectomy to asymptomatic gallstone in patients with or without NAFLD was 1.97 and 0.79, respectively. The rate of cholecystectomy was higher in the patients with NAFLD than in those without NAFLD (15.8% vs. 9.3%, P < 0.001), consistent with the result after case–control matching (17.3% vs. 11.2%, P < 0.001). Multivariate logistic regression analysis, after adjusting for numerous potential confounding factors, revealed that GSD (OR = 1.241, 95%CI: 1.036–1.488, P = 0.002) and cholecystectomy (OR = 1.946, 95%CI: 1.546–2.445, P < 0.001) were both strongly associated with NAFLD. However, asymptomatic gallstone (OR = 0.663, 95%CI: 0.513–0.856, P = 0.002) seemed to be negatively correlated with NAFLD. CONCLUSIONS: The prevalence of GSD was similar in patients with type 2 diabetes with and without NAFLD. The higher proportion of cholecystectomy and lower proportion of asymptomatic gallstones in patients with NAFLD suggests that NAFLD may increase the risk of complications of GSD. BioMed Central 2021-11-19 /pmc/articles/PMC8603504/ /pubmed/34794397 http://dx.doi.org/10.1186/s12902-021-00899-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lu, Ye
Hu, Lili
Song, Jing
Wan, Jing
Chen, Haibing
Yin, Jun
Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title_full Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title_fullStr Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title_full_unstemmed Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title_short Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
title_sort gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603504/
https://www.ncbi.nlm.nih.gov/pubmed/34794397
http://dx.doi.org/10.1186/s12902-021-00899-z
work_keys_str_mv AT luye gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy
AT hulili gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy
AT songjing gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy
AT wanjing gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy
AT chenhaibing gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy
AT yinjun gallstonediseaseandnonalcoholicfattyliverdiseaseinpatientswithtype2diabetesacrosssectionalstudy